Redecol has stepped in to this key problem space and has developed a new device to help asthmatics monitor their condition.
The device uses the Redecol breath sensor, a unique sensor which has IP protection. The device doesn’t need the hard, forced breathing technique that a peak flow meter needs. Just deep controlled breaths. The sensor creates a breath profile shape as a person breathes in and out over the sensor. The shape of this breath profile is analysed to provide information on the patient’s lung function and how symptomatic an asthmatic is.
Redecol are developing a prototype to be used in the current clinical studies to identify a device suitable for asthma sufferers to monitor their condition at home.
The commercial device fulfils many of the unmet needs found in the current home monitoring market devices:
It does not require forced breathing.
It has a straight forward user interface that guides the patient in using their device and monitoring and therefore managing their condition.
It links to their smart devices.
The device will automatically record the result and plot trends so that it can give an early warning when symptoms are starting to worsen so that the patient can alter their medicine use.
It allows patients to send their results to their doctor or asthma nurse so that they can offer further help and guidance in helping them to manage their condition.
Improved monitoring leads to improved asthma management and control. This leads to an improved life for the asthma sufferer, symptom free.